Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00107107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, open-label extension study designed to examine the long-term safety of pramlintide treatment in subjects with type 1 diabetes who have successfully completed treatment in the parent study 137-150.
Study identification
- NCT ID
- NCT00107107
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2002
- Primary completion
- May 31, 2005
- Completion
- May 31, 2005
- Last update posted
- Sep 22, 2015
2002 – 2005
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tempe | Arizona | — | — |
| Research Site | Concord | California | — | — |
| Research Site | Fresno | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Mateo | California | — | — |
| Research Site | Santa Barbara | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | Aventura | Florida | — | — |
| Research Site | Fort Myers | Florida | — | — |
| Research Site | New Port Richey | Florida | — | — |
| Research Site | Tallahassee | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Grand Rapids | Michigan | — | — |
| Research Site | City of Saint Peters | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Camp Hill | Pennsylvania | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Irving | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Renton | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00107107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00107107 live on ClinicalTrials.gov.